间充质干细胞在银屑病中的应用

doi:10.35541/cjd.20200152

Abstract

Abstract: 【Abstract】 Mesenchymal stem cells are an important member of the stem cell family, characterized by self-renewal ability, multipotent differentiation potential, immunomodulatory effects, low immunogenicity, etc. Studies have demonstrated varying degrees of clinical efficacy of mesenchymal stem cells in the treatment of psoriasis, with long remission periods. This review summarizes the application of mesenchymal stem cells in psoriasis and related research progress.

Key words: Psoriasis, Mesenchymal stem cells, Therapy, Recurrence

Wang Xiaoyu, Zhang Chunlei, Wang Wenhui. Application of mesenchymal stem cells in psoriasis[J].Chinese Journal of Dermatology, 2021,54(11):1019-1022.

References ［40］

［1］	Mushahary D, Spittler A, Kasper C, et al. Isolation, cultivation, and characterization of human mesenchymal stem cells［J］. Cytometry A, 2018,93（1）:19⁃31. doi: 10.1002/cyto.a.23242.
［2］	Chaudhary D, Trivedi RN, Kathuria A, et al. In vitro and In vivo immunomodulating properties of mesenchymal stem cells［J］. Recent Pat Inflamm Allergy Drug Discov, 2018,12（1）:59⁃68. doi: 10.2174/1872213X12666180227105924.
［3］	Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues［J］. Transplantation, 1968,6（2）:230⁃247.
［4］	Andrzejewska A, Lukomska B, Janowski M. Concise review: mesenchymal stem cells: from roots to boost［J］. Stem Cells, 2019,37（7）:855⁃864. doi: 10.1002/stem.3016.
［5］	Campanati A, Consales V, Orciani M, et al. Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives［J］. Psoriasis （Auckl）, 2017,7:73⁃85. doi: 10.2147/PTT.S108311.
［6］	Wang Q, Yang Q, Wang Z, et al. Comparative analysis of human mesenchymal stem cells from fetal⁃bone marrow, adipose tissue, and Warton′s jelly as sources of cell immunomodulatory therapy［J］. Hum Vaccin Immunother, 2016,12（1）:85⁃96. doi: 10.1080/21645515.2015.1030549.
［7］	Bougioukli S, Saitta B, Sugiyama O, et al. Lentiviral gene therapy for bone repair using human umbilical cord blood⁃derived mesenchymal stem cells［J］. Hum Gene Ther, 2019,30（7）:906⁃917. doi: 10.1089/hum.2018.054.
［8］	Damia E, Chicharro D, Lopez S, et al. Adipose⁃derived mesenchymal stem cells: are they a good therapeutic strategy for osteoarthritis?［J］. Int J Mol Sci, 2018,19（7）:1926. doi: 10.3390/ijms19071926.
［9］	Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue［J］. Stem Cells, 2006,24（5）:1294⁃1301. doi: 10.1634/stemcells.2005⁃0342.
［10］	Ayala⁃Cuellar AP, Kang JH, Jeung EB, et al. Roles of mesenchymal stem cells in tissue regeneration and immunomodulation［J］. Biomol Ther （Seoul）, 2019,27（1）:25⁃33. doi: 10.4062/biomolther.2017.260.
［11］	韩齐心, 牛旭平, 刘佳, 等. 间充质干细胞及其外泌体与Th17/Treg对银屑病发病机制的研究进展［J］. 中华皮肤科杂志, 2020,53（2）:151⁃154. doi: 10.35541/cjd.20190012.
［12］	Wang Y, Tian M, Wang F, et al. Understanding the immunological mechanisms of mesenchymal stem cells in allogeneic transplantation: from the aspect of major histocompatibility complex class I［J］. Stem Cells Dev, 2019,28（17）:1141⁃1150. doi: 10.1089/scd.2018.0256.
［13］	Bonfield TL, Nolan Koloze MT, Lennon DP, et al. Defining human mesenchymal stem cell efficacy in vivo［J］. J Inflamm （Lond）, 2010,7:51. doi: 10.1186/1476⁃9255⁃7⁃51.
［14］	Sah SK, Park KH, Yun CO, et al. Effects of human mesenchymal stem cells transduced with superoxide dismutase on imiquimod⁃induced psoriasis⁃like skin inflammation in mice［J］. Antioxid Redox Signal, 2016,24（5）:233⁃248. doi: 10.1089/ars.2015.6368.
［15］	Lee YS, Sah SK, Lee JH, et al. Human umbilical cord blood⁃derived mesenchymal stem cells ameliorate psoriasis⁃like skin inflammation in mice［J］. Biochem Biophys Rep, 2017,9:281⁃288. doi: 10.1016/j.bbrep.2016.10.002.
［16］	Kim JY, Park M, Kim YH, et al. Tonsil⁃derived mesenchymal stem cells （T⁃MSCs） prevent Th17⁃mediated autoimmune response via regulation of the programmed death⁃1/programmed death ligand⁃1 （PD⁃1/PD⁃L1） pathway［J］. J Tissue Eng Regen Med, 2018,12（2）:e1022⁃e1033. doi: 10.1002/term.2423.
［17］	Imai Y, Yamahara K, Hamada A, et al. Human amnion⁃derived mesenchymal stem cells ameliorate imiquimod⁃induced psoriasiform dermatitis in mice［J］. J Dermatol, 2019,46（3）:276⁃278. doi: 10.1111/1346⁃8138.14768.
［18］	刘瑞风, 杨晓红, 梁见楠, 等. 银屑病患者皮损间充质干细胞环状RNA表达异常研究［J］. 中华皮肤科杂志, 2018,51（10）:723⁃728. doi: 10.3760/cma.j.issn.0412⁃4030.2018.10.004.
［19］	Liu R, Chang W, Li J, et al. Mesenchymal stem cells in psoriatic lesions affect the skin microenvironment through circular RNA［J］. Exp Dermatol, 2019,28（3）:292⁃299. doi: 10.1111/exd.13890.
［20］	Liu R, Wang Q, Chang W, et al. Characterisation of the circular RNA landscape in mesenchymal stem cells from psoriatic skin lesions［J］. Eur J Dermatol, 2019,29（1）:29⁃38. doi: 10.1684/ejd. 2018.3483.
［21］	Campanati A, Orciani M, Consales V, et al. Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1⁃Th17/Th2 imbalance of psoriasis［J］. Arch Dermatol Res, 2014,306（10）:915⁃920. doi: 10.1007/s00403⁃ 014⁃1493⁃3.
［22］	Hou R, Yin G, An P, et al. DNA methylation of dermal MSCs in psoriasis: identification of epigenetically dysregulated genes［J］. J Dermatol Sci, 2013,72（2）:103⁃109. doi: 10.1016/j.jdermsci. 2013.07.002.
［23］	Orciani M, Campanati A, Salvolini E, et al. The mesenchymal stem cell profile in psoriasis［J］. Br J Dermatol, 2011,165（3）:585⁃592. doi: 10.1111/j.1365⁃2133.2011.10438.x.
［24］	Liu R, Wang Y, Zhao X, et al. Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin［J］. Eur J Dermatol, 2014,24（5）:560⁃567. doi: 10.1684/ejd.2014. 2394.
［25］	Chen H, Niu JW, Ning HM, et al. Treatment of psoriasis with mesenchymal stem cells［J］. Am J Med, 2016,129（3）:e13⁃14. doi: 10.1016/j.amjmed.2015.11.001.
［26］	De Jesus MM, Santiago JS, Trinidad CV, et al. Autologous adipose⁃derived mesenchymal stromal cells for the treatment of psoriasis vulgaris and psoriatic arthritis: a case report［J］. Cell Transplant, 2016,25（11）:2063⁃2069. doi: 10.3727/096368 916X691998.
［27］	Comella K, Parlo M, Daly R, et al. First⁃in⁃man intravenous implantation of stromal vascular fraction in psoriasis: a case study［J］. Int Med Case Rep J, 2018,11:59⁃64. doi: 10.2147/IMCRJ.S163612.
［28］	Seetharaman R, Mahmood A, Kshatriya P, et al. Mesenchymal stem cell conditioned media ameliorate psoriasis vulgaris: a case study［J］. Case Rep Dermatol Med, 2019,2019:8309103. doi: 10.1155/2019/8309103.
［29］	Mendicino M, Bailey AM, Wonnacott K, et al. MSC⁃based product characterization for clinical trials: an FDA perspective［J］. Cell Stem Cell, 2014,14（2）:141⁃145. doi: 10.1016/j.stem. 2014.01.013.
［30］	Tarte K, Gaillard J, Lataillade JJ, et al. Clinical⁃grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation［J］. Blood, 2010,115（8）:1549⁃1553. doi: 10.1182/blood⁃2009⁃05⁃219907.
［31］	Crowder SW, Horton LW, Lee SH, et al. Passage⁃dependent cancerous transformation of human mesenchymal stem cells under carcinogenic hypoxia［J］. FASEB J, 2013,27（7）:2788⁃2798. doi: 10.1096/fj.13⁃228288.
［32］	Lazennec G, Lam PY. Recent discoveries concerning the tumor ⁃ mesenchymal stem cell interactions［J］. Biochim Biophys Acta, 2016,1866（2）:290⁃299. doi: 10.1016/j.bbcan.2016.10.004.
［33］	Jung JW, Kwon M, Choi JC, et al. Familial occurrence of pulmonary embolism after intravenous, adipose tissue⁃derived stem cell therapy［J］. Yonsei Med J, 2013,54（5）:1293⁃1296. doi: 10.3349/ymj.2013.54.5.1293.
［34］	Furlani D, Ugurlucan M, Ong L, et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy［J］. Microvasc Res, 2009,77（3）:370⁃376. doi: 10.1016/j.mvr.2009.02.001.
［35］	Xu XM, Luo H, Rong BB, et al. Management of delayed encephalopathy after CO poisoning: an evidence⁃based narrative review［J］. Medicine （Baltimore）, 2019,98（49）:e18199. doi: 10. 1097/MD.0000000000018199.
［36］	赵鸣悦, 符粤文, 王倩, 等. 脐血间充质干细胞在难治性重型再生障碍性贫血异基因造血干细胞移植中的应用［J］. 中华血液学杂志, 2019,40（9）:726⁃731. doi: 10.3760/cma.j.issn. 0253⁃2727.2019.09.003.
［37］	Jayaraj JS, Janapala RN, Qaseem A, et al. Efficacy and safety of stem cell therapy in advanced heart failure patients: a systematic review with a meta⁃analysis of recent trials between 2017 and 2019［J］. Cureus, 2019,11（9）:e5585. doi: 10. 7759/cureus.5585.
［38］	Zhang Y, Chen W, Feng B, et al. The clinical efficacy and safety of stem cell therapy for diabetes mellitus: a systematic review and meta⁃analysis［J］. Aging Dis, 2020,11（1）:141⁃153. doi: 10.14336/AD.2019.0421.
［39］	Thompson M, Mei S, Wolfe D, et al. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta⁃analysis［J/OL］. E Clinical Medicine, 2020,19:100249［2021⁃03⁃12］. https://www.thelancet.com/journals/eclinm/article/PIIS2589⁃5370(19)30258⁃5/fulltext. doi: 10.1016/ j.eclinm.2019.100249.
［40］	Gu J, Huang L, Zhang C, et al. Therapeutic evidence of umbilical cord⁃derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial［J］. Stem Cell Res Ther, 2020,11（1）:43. doi: 10.1186/s13287⁃019⁃1545⁃x.

[1]	Zhang Ning, Li Shu, Li Jing . Efficacy of immune checkpoint inhibitors and targeted therapy in adjuvant treatment of resectable melanoma: a network meta-analysis [J]. Chinese Journal of Dermatology, 2022, 0(4): 20200767-e20200767.
[2]	Li Yan, Li Ming, Xu Wei, Li Linfeng. Efficacy of fluticasone propionate cream alone or in combination with calcipotriol ointment in the treatment of mild to moderate plaque psoriasis: a randomized self-controlled study [J]. Chinese Journal of Dermatology, 2022, 0(4): 20210246-e20210246.
[3]	Li Sai, Xue Huazhong, Zhang Shuwen, Jiang Juan, Qi Shuzhen, Zhao Yuanyuan, Zhang Jinping, Sha Zhong, Le Wenjing, Wang Biwei, Zhao Shixuan, Zhu Xiaofeng, Su Xiaohong. Doxycycline-moxifloxacin sequential therapy for Mycoplasma genitalium urethritis/cervicitis: a clinical observation [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210631-e20210631.
[4]	Wang Yue, Yan Yulin. Analysis of acitretin-related adverse reactions and reasons for drug discontinuation in 171 patients with psoriasis vulgaris [J]. Chinese Journal of Dermatology, 2022, 0(2): 20200867-e20200867.
[5]	Jiao Xiaoyan, Yin Guangwen, Yin Yakun, Li Dongqin. Clinical analysis of 25 cases of herpes zoster during pregnancy or the perinatal period [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210384-e20210384.
[6]	Ou Min, Yan Yunling, Zheng Baoqing, Wang Xiaohua. Correlations between psoriasis and obesity [J]. Chinese Journal of Dermatology, 2022, 55(2): 181-184.
[7]	Bao Shijie, Cheng Yang, Yan Ying, Fan Fang, Gao Tingting, Feng Xiaolan, Zheng Liang, Lei Wei, Huang Qinsi, Zhang Weiming, Zhou Xiaoyong. A comparative study of human immunoglobulin versus recombinant human tumor necrosis factor-α receptor Ⅱ:IgG Fc fusion protein in the treatment of toxic epidermal necrolysis [J]. Chinese Journal of Dermatology, 2022, 55(2): 153-156.
[8]	Guo Jing, Yang Jingyu, Ding Li, Liu Mingming, Hou Jingmei, Pu Xiaoxia, Sun Jiayu, Li Xianghua. Efficacy of long-pulsed 1 064-nm Nd:YAG laser combined with a topical emulsion containing Camellia reticulata and Radix Notoginseng in the treatment of melasma [J]. Chinese Journal of Dermatology, 2022, 55(1): 61-64.
[9]	Zhao Ying, Wang Juanjuan, Ji Jiang, Su Wenxing, Wei Yuqian, Leng Hong, Ding Yujie, Shi Xin. Interleukin-17A-mediated psoriasis and cardiovascular comorbidities [J]. Chinese Journal of Dermatology, 2022, 55(1): 76-79.
[10]	Chinese Society of Dermatology, China Dermatologist Association. Consensus on the diagnosis and treatment of autoimmune subepidermal bullous diseases （2022） [J]. Chinese Journal of Dermatology, 2022, 55(1): 1-11.
[11]	Luan Chao, Hu Yu, Chen Kun, Zhang Jiaan, Gu Heng, Zhang Ronglin, Zhang Xiaohua, Tian Panpan, Zhu Yan, Zhuang Chen, Huang Dan, Ju Mei. Efficacy and safety of 308-nm SQ light-emitting diode light and 308-nm excimer light in the treatment of facial vitiligo: a retrospective study [J]. Chinese Journal of Dermatology, 2022, 55(1): 16-19.
[12]	Lu Jiawei, Lu Yan. Paradoxical psoriasis induced by tumor necrosis factor-α inhibitors and other biological agents [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210420-e20210420.
[13]	Gao Rong, Zhang Lan, Li Zhengxiao. Biological agents in the treatment of moderate to severe plaque psoriasis and psoriatic arthritis [J]. Chinese Journal of Dermatology, 2022, 55(1): 72-75.
[14]	Lin Luyang, Chen Zhengliang, Zhang Xibao. Major immune-related cells in psoriasis vulgaris lesions [J]. Chinese Journal of Dermatology, 2021, 54(9): 830-834.
[15]	Qiu Yueqi, Fu Siqi, Luo Shuaihantian, Li Yaping, Zhang Guiying. Research advance in androgenetic alopecia in 2020 [J]. Chinese Journal of Dermatology, 2021, 54(9): 835-838.

Application of mesenchymal stem cells in psoriasis

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［40］

Related Articles 15

Metrics

Comments

Recommended 10